3 results
Approved WMOPending
Primary Objective- Compare the safety and efficacy of subcutaneous somavaratan and daily rhGH during 12 months of treatment.Secondary Objective-Evaluate and compare changes in pharmacodynamic responses (IGF-I, IGF binding protein-3 (IGFBP-3), growth…
Approved WMOCompleted
To evaluate the safety and clinical performance of the LCP system in patients who are indicated for VVI(R) pacemaker.
Approved WMOWill not start
To compare the safety and efficacy of different doses and regimens of Allocetra-OTS to that of Placebo in the treatment of organ failure in adult sepsis patients